International Multi-center Comparative Randomized Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Netakimab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Biocad
- 26 Apr 2018 Results presented in the Biocad media release.
- 14 Jul 2017 Status changed from recruiting to completed.
- 06 Apr 2017 Status changed from not yet recruiting to recruiting.